Skip to Main Content

Karyopharm Therapeutics Inc.

KPTI Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
KPTI Income Statement
KPTI Balance Sheet
KPTI Cash Flow

Recent trades of KPTI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
KPTI Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
KPTI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
KPTI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by KPTI's directors and management

Government lobbying spending instances

  • $40,000 Jan 21, 2020 Issue: Pharmacy
  • $60,000 Oct 21, 2019 Issue: Pharmacy
  • $60,000 Jul 22, 2019 Issue: Pharmacy
  • $60,000 Apr 22, 2019 Issue: Pharmacy
  • $60,000 Jan 23, 2019 Issue: Pharmacy

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Nuclear transport modulators and uses thereof Apr. 02, 2024
  • Patent Title: Polymorphs of selinexor Nov. 07, 2023
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Oct. 17, 2023
  • Patent Title: Polymorphs of selinexor Sep. 12, 2023
  • Patent Title: Polymorphs of selinexor Sep. 05, 2023
  • Patent Title: Nuclear transport modulators and uses thereof Sep. 21, 2021
  • Patent Title: Polymorphs of selinexor Aug. 03, 2021
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Jun. 15, 2021
  • Patent Title: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof May. 18, 2021
  • Patent Title: Multicyclic compounds and uses thereof Dec. 08, 2020
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Jan. 28, 2020
  • Patent Title: Nuclear transport modulators and uses thereof Jan. 07, 2020
  • Patent Title: Polymorphs of selinexor Dec. 31, 2019
  • Patent Title: Nuclear transport modulators and uses thereof Sep. 10, 2019
  • Patent Title: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Sep. 03, 2019
  • Patent Title: (s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer Jul. 30, 2019
  • Patent Title: Methods of promoting wound healing using crm1 inhibitors Feb. 12, 2019
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Jan. 08, 2019
  • Patent Title: Multicyclic compounds and methods of using same Jun. 12, 2018
  • Patent Title: Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof Apr. 10, 2018
  • Patent Title: Nuclear transport modulators and uses thereof Jan. 09, 2018
  • Patent Title: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Jan. 02, 2018
  • Patent Title: Nuclear transport modulators and uses thereof Aug. 22, 2017
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Jul. 25, 2017
  • Patent Title: Nuclear transport modulators and uses thereof Mar. 07, 2017
  • Patent Title: Nuclear transport modulators and uses thereof Jan. 24, 2017
  • Patent Title: Nuclear transport modulators and uses thereof Aug. 30, 2016
  • Patent Title: Olefin containing nuclear transport modulators and uses thereof Apr. 05, 2016
  • Patent Title: Nuclear transport modulators and uses thereof Feb. 23, 2016
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Dec. 08, 2015
  • Patent Title: Nuclear transport modulators and uses thereof Aug. 04, 2015
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Jul. 14, 2015
  • Patent Title: Hydrazide containing nuclear transport modulators and uses thereof Apr. 07, 2015
  • Patent Title: Nuclear transport modulators and uses thereof Aug. 20, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of KPTI in WallStreetBets Daily Discussion

KPTI News

Recent insights relating to KPTI

CNBC Recommendations

Recent picks made for KPTI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KPTI

KPTI Top Shareholders
Shareholder
Shares Held
KPTI Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

KPTI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view KPTI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top